Related references
Note: Only part of the references are listed.The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2017)
Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis
Wilson Wong et al.
NATURE MICROBIOLOGY (2017)
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites
L. Dembele et al.
SCIENTIFIC REPORTS (2017)
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
Bui Quang Phuc et al.
EMERGING INFECTIOUS DISEASES (2017)
pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom
Colin J. Sutherland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins
Stanley C. Xie et al.
JOURNAL OF CELL SCIENCE (2016)
The Spiroindolone KAE609 Does Not Induce Dormant Ring Stages in Plasmodium falciparum Parasites
Marina Chavchich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors
Aung Pyae Phyo et al.
CLINICAL INFECTIOUS DISEASES (2016)
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
Chanaki Amaratunga et al.
LANCET INFECTIOUS DISEASES (2016)
K13-Propeller Mutations and Malaria Resistance
Johanna P. Daily
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
D. Menard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Artemisinin Action and Resistance in Plasmodium falciparum
Leann Tilley et al.
TRENDS IN PARASITOLOGY (2016)
Mutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance
Gregory LaMonte et al.
MBIO (2016)
UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes
Michelle Yi-Xiu Lim et al.
NATURE MICROBIOLOGY (2016)
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment
Rithea Leang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Mitochondrial Membrane Potential in a Small Subset of Artemisinin-Induced Dormant Plasmodium falciparum Parasites In Vitro
Christopher L. Peatey et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study
Michele D. Spring et al.
LANCET INFECTIOUS DISEASES (2015)
Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance
Con Dogovski et al.
PLOS BIOLOGY (2015)
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Judith Straimer et al.
SCIENCE (2015)
Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure
Sandie Menard et al.
EMERGING INFECTIOUS DISEASES (2015)
Laboratory Detection of Artemisinin-Resistant Plasmodium falciparum
Kesinee Chotivanich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
F. Joel Leong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Kelli L. Kuhen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Spiroindolone KAE609 for Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dihydroartemisinin-Piperaquine Failure in Cambodia
David L. Saunders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Lead Optimization of Imidazopyrazines: A New Class of Antimalarial with Activity on Plasmodium Liver Stages
Bin Zou et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia
Benoit Witkowski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Defining the Timing of Action of Antimalarial Drugs against Plasmodium falciparum
Danny W. Wilson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2013)
Targeting Plasmodium PI(4)K to eliminate malaria
Case W. McNamara et al.
NATURE (2013)
Altered temporal response of malaria parasites determines differential sensitivity to artemisinin
Nectarios Klonis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Phenotypic Changes in Artemisinin-Resistant Plasmodium falciparum Lines In Vitro: Evidence for Decreased Sensitivity to Dormancy and Growth Inhibition
Franka Teuscher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Aung Pyae Phyo et al.
LANCET (2012)
Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania
Anna Farnert et al.
MALARIA JOURNAL (2012)
In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam
Tran Tinh Hien et al.
MALARIA JOURNAL (2012)
Effects of Artesunate on Parasite Recrudescence and Dormancy in the Rodent Malaria Model Plasmodium vinckei
Alexis N. LaCrue et al.
PLOS ONE (2011)
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Stephan Meister et al.
SCIENCE (2011)
Increased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence Mechanism
Benoit Witkowski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Artemisinin-Induced Dormancy in Plasmodium falciparum: Duration, Recovery Rates, and Implications in Treatment Failure
Franka Teuscher et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Pharmacokinetics and Ex Vivo Pharmacodynamic Antimalarial Activity of Dihydroartemisinin-Piperaquine in Patients with Uncomplicated Falciparum Malaria in Vietnam
Dao Van Hoang Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia
William O. Rogers et al.
MALARIA JOURNAL (2009)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Qinghaosu (Artemisinin): The price of success
N. J. White
SCIENCE (2008)
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa
Christin Sisowath et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS-dependent pathway
FJ Fernandez-Gomez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand:: a prospective study
F Nosten et al.
LANCET (2000)
Share Paper
